Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodium

por Konovalova, Irina S., Kovalenko, Sergiy M., Kravchenko, Dmitry V., Chuev, Vladimir P.
Publicado 2021

(1R,3S)-3-(1H-Benzo[d]imidazol-2-yl)-1,2,2-tri­methyl­cyclo­pentane-1-carb­oxy­lic acid as a new anti-diabetic active pharmaceutical ingredient

por Kovalenko, Sergiy M., Konovalova, Irina S., Merzlikin, Sergiy I., Chuev, Vladimir P., Kravchenko, Dmitry V.
Publicado 2020

Crystal structure, Hirshfeld analysis and a mol­ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa­diazo...

por Ivachtchenko, Alexandre V., Kovalenko, Sergiy M., Kravchenko, Dmitry V., Mitkin, Oleg D., Ivanov, Vladimir V., Langer, Thierry
Publicado 2020

The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2

por Ivashchenko, Andrey A., Zagribelnyy, Bogdan A., Ivanenkov, Yan A., Ivashchenko, Ilya A., Karapetian, Ruben N., Kravchenko, Dmitry V., Savchuk, Nikolay P., Yakubova, Elena V., Ivachtchenko, Alexandre V.
Publicado 2022

Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophe...

por Ivachtchenko, Alexandre V., Mitkin, Oleg D., Kravchenko, Dmitry V., Kovalenko, Sergiy M., Shishkina, Svitlana V., Bunyatyan, Natalya D., Konovalova, Irina S., Dmitrieva, Irina G., Ivanov, Vladimir V., Langer, Thierry
Publicado 2019

Methylation of Methyl 4-Hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate: Synthetic, Crystallographic, and Molecular Docking Studies

por Kovalenko, Sergiy M., Drushlyak, Oleksandr G., Shishkina, Svitlana V., Konovalova, Irina S., Mariutsa, Illia O., Bunyatyan, Natalya D., Kravchenko, Dmitry V., Ivanov, Vladimir V., Ivachtchenko, Alexandre V., Langer, Thierry
Publicado 2020

Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment

por Ivachtchenko, Alexandre V., Mitkin, Oleg D., Kudan, Elizaveta V., Rjahovsky, Alexey A., Vorobiev, Anton A., Trifelenkov, Andrey S., Shevkun, Natalia A., Proskurina, Oxana V., Kravchenko, Dmitry V., Karapetian, Ruben N.
Publicado 2014

Effect of Aprotinin and Avifavir(®) Combination Therapy for Moderate COVID-19 Patients

por Ivashchenko, Andrey A., Azarova, Valeria N., Egorova, Alina N., Karapetian, Ruben N., Kravchenko, Dmitry V., Krivonos, Natalia V., Loginov, Vladimir G., Poyarkov, Stanislav V., Merkulova, Elena A., Rosinkova, Olga S., Savchuk, Nikolay P., Topr, Mikhail A., Simakina, Elena N., Yakubova, Elena V., Ivachtchenko, Alexandre V.
Publicado 2021

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

por Ivashchenko, Andrey A, Dmitriev, Kirill A, Vostokova, Natalia V, Azarova, Valeria N, Blinow, Andrew A, Egorova, Alina N, Gordeev, Ivan G, Ilin, Alexey P, Karapetian, Ruben N, Kravchenko, Dmitry V, Lomakin, Nikita V, Merkulova, Elena A, Papazova, Natalia A, Pavlikova, Elena P, Savchuk, Nikolay P, Simakina, Elena N, Sitdekov, Tagir A, Smolyarchuk, Elena A, Tikhomolova, Elena G, Yakubova, Elena V, Ivachtchenko, Alexandre V
Publicado 2020